RAD51B and ovarian carcinoma: In our cohort of 3422 index breast and ovarian cancer cases, we found RAD51B loss-of-function germline variants (9/3422 cases) to be almost as common as those affecting RAD51C and RAD51D (combined 16/3422 cases).